Chesapeake Wealth Management Dexcom Inc Transaction History

Chesapeake Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$67.99 - $132.89 $30,867 - $60,332	-454 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$94.08 - $130.2 $14,112 - $19,530	-150 Reduced 24.83%	454 $233,000
Q4 2021 Feb 03, 2022	SELL	$129.87 - $162.82 $5,584 - $7,001	-43 Reduced 6.65%	604 $324,000
Q3 2021 Oct 26, 2021	SELL	$106.71 - $143.18 $32,439 - $43,526	-304 Reduced 31.97%	647 $354,000
Q2 2021 Jul 29, 2021	SELL	$80.99 - $107.93 $75,401 - $100,482	-931 Reduced 49.47%	951 $406,000
Q1 2021 Apr 26, 2021	BUY	$84.79 - $104.74 $17,127 - $21,157	202 Added 12.02%	1,882 $676,000
Q4 2020 Feb 05, 2021	BUY	$78.0 - $104.5 $51,168 - $68,552	656 Added 64.06%	1,680 $622,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $97,802 - $115,660	1,024 New	1,024 $422,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.